Cleveland Clinic Revives Heart-Disease Test Patent Row
The complaint alleges that True Health is infringing U.S. Patent No. 9,575,065 — which is owned by the foundation and licensed exclusively to co-plaintiff Cleveland HeartLab Inc. — by using myeloperoxidase testing, which assesses cardiovascular disease risk by analyzing blood vessel inflammation.
The suit comes almost exactly...
To view the full article, register now.